<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Plasma Cell Disorders (Part 2)</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Plasma Cell Disorders (Part 2)</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                11 Questions | 11 Total Marks | 21 min Duration | ~114.55 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 11 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 21 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 11</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Plasma Cell Disorders (Part 2) - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 11</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 11 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "In multiple myeloma, all of the following are seen except", "options": [{"label": "A", "text": "Anion gap raised", "correct": true}, {"label": "B", "text": "Lytic bone lesion", "correct": false}, {"label": "C", "text": "Polyarticular pain", "correct": false}, {"label": "D", "text": "M spike present with polyradiculopathy", "correct": false}], "correct_answer": "A. Anion gap raised", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Anion gap raised Investigations of MM:- Renal function tests (blood urea, creatinine, electrolytes) 2. Blood calcium and albumin (hypercalcemia) 3. A bone scan is normal 4. Plasma Ig level (degree of immune paresis) 5 . Serum Î²2 microglobulin . It is the single best parameter to tell about a poor prognosis. 6 . ESR is highly raised. 7 . CRP & â†‘ IL-6 ( CRP is a surrogated marker of IL-6, which is referred as Plasma Cell growth factor) 8. Plasma cell - a. Increase Acid phosphate b. Increase Glucuronidase 9. Pseudohyponatremia occurs. 10. Anion gap is decreased as the M component is cationic resulting in the retention of chloride. 11. Betaâ€“2 microglobulin levels are the single most important poor prognostic factor. Options B, C, and D are seen in multiple myeloma .</p>\n<p><strong>Extraedge:</strong></p><p>Hypercalcemia Causes AKI in Multiple Myeloma. Myeloma light chains can also cause AKI by glomerular damage and/or direct tubular toxicity and by binding to Tamm-Horsfall protein to form obstructing intratubular casts. A low anion gap with AKI may provide a clue to the diagnosis of multiple myeloma due to the presence of unmeasured cationic proteins.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Bortezomib is used in the treatment of?", "options": [{"label": "A", "text": "AML", "correct": false}, {"label": "B", "text": "ALL", "correct": false}, {"label": "C", "text": "MM", "correct": true}, {"label": "D", "text": "CML", "correct": false}], "correct_answer": "C. MM", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>MM Management of Multiple Myeloma:- C-Cyclophosphamide; D-Dexamethasone; Melphalan; P-Prednisolone;R-Lenalidomide RVD Lite-, Weekly regimen; V-Bortezomib.Alternative regimens indicate combinations including daratumumab, elotuzumab, Panobinostat, Carfilzomib, ixazomib, and pomalidomideHDT-High dose therapyMDE-Myeloma defining events.ASCT=Autologous stem cell transplant therapy</p>\n<p><strong>Extraedge:</strong></p><p>Estimated 5-year survival rate in multiple myeloma patients after autologous bone marrow transplant- 60%</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 66 year old male patient who came to OPD with complaints of fatigue and weakness and bone pain was admitted for further evaluation. After investigations, he was diagnosed with multiple myeloma. Later on, he also developed symptoms like headache, blurring of vision, and tinnitus. Also, he felt a tingling sensation and pain running down from the back to the left leg. Which of the following given symptoms are not because of the hyperviscosity in the blood?", "options": [{"label": "A", "text": "Headache", "correct": false}, {"label": "B", "text": "Blurring of vision", "correct": false}, {"label": "C", "text": "Tingling sensation", "correct": true}, {"label": "D", "text": "Tinnitus", "correct": false}], "correct_answer": "C. Tingling sensation", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Tingling sensation In a patient with multiple myeloma, it is common to have hyperviscosity syndrome due to the monoclonal proliferation of the antibodies. These symptoms include- Headache B. Blurring of vision D. Tinnitus. Option C. Tingling sensation and pain running down from the back and to the left leg is basically defining radiculopathy and it results from compression by vertebral fractures due to osteolysis. Hence, the answer to this question will be option C.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 72 year old man with complaints of easy fatigability and chronic lower back ache has undergone certain investigations which are shown below- Hb- 8.2 g/dl; S.Ca- 12 mg/dl; serum M protein- 55 g/l with b/m biopsy showing 25% plasma cells. What is the likely diagnosis for this patient?", "options": [{"label": "A", "text": "Smoldering multiple myeloma", "correct": false}, {"label": "B", "text": "MGUS", "correct": false}, {"label": "C", "text": "Multiple myeloma", "correct": true}, {"label": "D", "text": "Plasma cell leukemia", "correct": false}], "correct_answer": "C. Multiple myeloma", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Multiple myeloma In this scenario, the patient with features like fatigability and weakness, presence of bone pain along with laboratory findings suggesting anemia, hypercalcemia, and increased M protein >30g/l with B/M clonal plasma cells >10%, the most likely diagnosis will be multiple myeloma.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Smoldering MM can have the same lab findings as MM but there is no evidence of End organ damage or CRAB features. Optio n MGUS will have no CRAB features and BM clonal plasma cells will be <10%. Option C. Plasma cell leukemia will show the presence of plasma cells in the blood . Hence, it is not the answer to this question.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 76 year old man who was diagnosed with multiple myeloma 1 year back died 2 days back after being admitted to the hospital for a while now. What is the most common cause of death in these patients?", "options": [{"label": "A", "text": "Renal failure", "correct": false}, {"label": "B", "text": "Hyperviscosity syndrome causing thrombosis", "correct": false}, {"label": "C", "text": "Infections", "correct": true}, {"label": "D", "text": "Hypercalcemia.", "correct": false}], "correct_answer": "C. Infections", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Infections In patients with multiple myeloma, the most common cause of death is infections due to functional Ig hypo gamma globulinemia.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Renal failure may lead to death in such patients but is not the most common cause. Option B. Hyperviscosity syndromes can cause symptoms like headache, blurring of vision, but not death. Option D . Hypercalcemia can lead to renal failure and can lead to death eventually but not the most common cause.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient was brought to the hospital with complaints of dehydration and generalized weakness. He was diagnosed with multiple myeloma 1 year back. His ABG analysis was done which showed the following- pH- 7.1, HCO3- : 16 mEq/l, Pco2- 28 mm of hg, K+ 2.8 mEq/l. urine analysis showed proteinuria and glycosuria with Ph â€“ 5.2. What is the most likely diagnosis?", "options": [{"label": "A", "text": "RTA type 1", "correct": false}, {"label": "B", "text": "RTA type 2", "correct": false}, {"label": "C", "text": "Adult Fanconiâ€™s syndrome.", "correct": false}, {"label": "D", "text": "Both B and C", "correct": true}], "correct_answer": "D. Both B and C", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Both B and C In this patient with hypokalemia and urine pH of 5.2, type 2 RTA -also known as Adult Fanconiâ€™s syndrome is the likely diagnosis. It is associated with multiple myeloma. Due to the increased amount of light chains in the tubular cells of the kidney, there is proximal tubular damage which results in RTA type 2. The clinical features present in RTA type 2 are- Metabolic acidosis, as in this patient. Urine Ph<5.3 Proteinuria Glycosuria Hence, the diagnosis will be RTA type 2.</p>\n<p><strong>Random:</strong></p><p>Option A. RTA type 1- in this, the urinary Ph will BE >5.5, and also hco3- levels will be <15.</p>\n<p><strong>Extraedge:</strong></p><p>The earliest manifestation of tubular damage in multiple myeloma is adult Fanconiâ€™s syndrome (a type 2 proximal renal tubular acidosis) , with loss of glucose and amino acids, as well as defects in the ability of the kidney to acidify and concentrate the urine Acquired VWD or von Willebrand syndrome is most commonly seen in patients with underlying lymphoproliferative disorders, including monoclonal gammopathies of undetermined significance (MGUS), multiple myeloma, and WaldenstrÃ¶mâ€™s macroglobulinemia</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 72 year old male presented to OPD with increasing tiredness day by day along with pain in the bones of his legs. Certain blood tests were done. The findings are given below- Hb- 7.8g/dl; S. ca- 11.8 mg/dl; S.Cr- 2.2 mg/dl. Which of the following is a reliable prognostic marker in this patient?", "options": [{"label": "A", "text": "Plasma cell labeling index", "correct": false}, {"label": "B", "text": "B/M % of plasma cells.", "correct": false}, {"label": "C", "text": "Beta-2 microglobulin", "correct": true}, {"label": "D", "text": "Beta-2 transferrin", "correct": false}], "correct_answer": "C. Beta-2 microglobulin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Beta-2 microglobulin Serum Beta -2 microglobulin is a reliable indicator or prognostic marker in patients with multiple myeloma. It is used in combination with albumin. Patients with B-2 microglobulin levels <3.5 mg/l and albumin levels>3.5g/dl are said to have a median survival period of 5 years.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Plasma cell labeling index is already associated with poor prognosis. Option B. B/M plasma cells are not a marker of prognosis. Rather circulating plasma cells in the blood are markers of poor prognosis. Optio n D . B-2 transferrin is used for the diagnosis of CSF rhinorrhea and not multiple myeloma.</p>\n<p><strong>Extraedge:</strong></p><p>Risk Stratification in Myeloma CHROMOSOMAL ABNORMALITIES (CA METHOD STANDARD RISK (80%) (EXPECTED SURVIVAL 6-7+ YEARS HIGH RISK (20%) (EXPECTED SURVIVAL  2-3 YEARS) Karyotype Any abnormality on conventional karyotype FISH t(11;14) del(13) del(17p) t(4:14) t(14:16) t(14:20) amp 1q34 INTERNATIONAL STAGING SYSTEM (ISS) STAGE MEDIAN SURVIVAL MONTHS Î² 2 M <3.5 ,albâ‰¥3.5 I(28%) 3 62 Î² 2 M <3.5, alb <3.5 or Î² 2 M=3.5-5.5 II(39%) 44 Î² 2 M>5.5 III(33%) 29 REVISED INTERNATIONAL STAGING SYSTEM (R-ISS Stage I: ISS stage 1; standard risk for CA and normal LDH Stage II: Patients not meeting criteria for stage I or stage III Stage III: ISS stage III and either high risk for CA or high LDH Other features suggesting high-risk disease: De novo plasma cell leukemia Extramedullary disease Elevated LDH High-risk gene expression profile</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 66 year old male presented to OPD with the presence of multiple fractures and complain of bone pain in the past few months. His previous blood test revealed that he has anemia, and RFT was deranged. A bone marrow biopsy was done and showed the following. Which of the following is a poor prognostic marker in this patient?", "options": [{"label": "A", "text": "Deletion of 17q", "correct": false}, {"label": "B", "text": "T(11:14)", "correct": false}, {"label": "C", "text": "T(4:14)", "correct": false}, {"label": "D", "text": "Both A and C", "correct": true}], "correct_answer": "D. Both A and C", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1684545883979-QTDM087009IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Both A and C In the given question, the patient